期刊文献+

克罗恩病术后并发症的防治

下载PDF
导出
出处 《腹部外科》 2002年第3期138-140,共3页 Journal of Abdominal Surgery
  • 引文网络
  • 相关文献

参考文献1

二级参考文献46

  • 1[2]Hanaauer SB,Meyers S Management of Crohn's disease in adults.Am J Gastroenterol,1997;92:559-566
  • 2[4]Seo M,Okada M,Yao T.The role of total parenteral nutrition in the management of patients with acute attacks of inflammatory bowel disease [ see comments].J Clin G astroenterol,1999 ;29:270 - 275
  • 3[5]Hen PD,Burke A,Baldassano RN.Nutrition and inflammatory bowel disease.Gastroenterol Clin North Am,1999;28:423-443
  • 4[6]Husain A,Korzenik JR.Nutritional issues and therapy in inflammatory bowel disease.Semin Gastrointest Dis,1998;9:21-30
  • 5[7]Geerling BJ,Badart-Smook A,van Deursen C,van Houwelingen AC,Russel MG,Stockbrugger RW,Brummer RJ.Nutritional supplementation with N-3fatty acids and antioxidants in patients with Crohn's disease in remission:effects on antioxidant status and fatty acid profile.Inflamm Bowel Dis,2000; 6:77 - 84
  • 6[8]Akobeng AK,Miller V,Stanton J.Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease.J Pediatr Gastroenterol Nutr ,2000;30:78 -84
  • 7[9]Hilsden RJ,Scott CM,Verhoef MJ.Complementary medicine use by patients with inflammatory bowel disease [see comments].Am J Gastroenterol,1998;93:697-701
  • 8[10]Clemett D,Markham A.Prolonged-release mesalazine:a review of its therapeutic potential in ulcerative colitis and Crohn's disease.Drugs,2000;59:929- 956
  • 9[11]Wahl C,Liptay S,Adler G.Sulfasalazine:a potent and specific inhibitor of nuclear factor kappa B.J Clin Invest,1998;101:1163 - 1174
  • 10[12]Irvine EJ,Greenberg GR,Feagan BG,Martin F,Sutherland LR,ThomsonAB,Nilsson LG,Persson T.Quality of life rapidly improves with budesonide therapy for active Crohn's disease.Canadian Inflammatory Bowel Disease Study Group.Inflamm Bowel Dis,2000; 6:181 - 187

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部